Health Notices




NEW ZEALAND GAZETTE, No. 61

3 JUNE 2010


Health Practitioners Competence Assurance Act 2003

Reappointment/appointments to the Physiotherapy Board

Pursuant to section 120 of the Health Practitioners Competence Assurance Act 2003, I reappoint

Lesley Thornley

as a health practitioner member of the Physiotherapy Board for a three-year term of office commencing on 3 July 2010;
and appoint

Maarama Davis
Janice Mueller

as health practitioner members of the Physiotherapy Board for three-year terms of office commencing on 3 July 2010;
and appoint

Michéle Stanton

as a lay member of the Physiotherapy Board for a three-year term of office commencing on 3 July 2010.

Dated at Wellington this 24th day of May 2010.

HON TONY RYALL, Minister of Health.

go4066


Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Pegasys
Active Ingredient: Peginterferon alfa-2a 270µg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Roche Products (NZ) Limited
Manufacturers: Roche Diagnostics GmbH, Mannheim, Germany
F Hoffmann-La Roche Limited, Basel, Switzerland

Product: Pegasys
Active Ingredient: Peginterferon alfa-2a 360µg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Roche Products (NZ) Limited
Manufacturers: Roche Diagnostics GmbH, Mannheim, Germany
F Hoffmann-La Roche Limited, Basel, Switzerland

Product: Pegasys RBV (Combination Product)
Active Ingredient: Peginterferon alfa-2a 270µg/mL
Dosage Form: Solution for injection
Active Ingredient: Ribavirin 200mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Roche Products (NZ) Limited
Manufacturers: Roche Diagnostics GmbH, Mannheim, Germany
F Hoffmann-La Roche Limited, Basel, Switzerland
Hoffmann-La Roche Inc, Nutley, United States of America
Patheon Inc, Mississauga, Canada

Product: Pegasys RBV (Combination Product)
Active Ingredient: Peginterferon alfa-2a 360µg/mL
Dosage Form: Solution for injection
Active Ingredient: Ribavirin 200mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Roche Products (NZ) Limited
Manufacturers: Roche Diagnostics GmbH, Mannheim, Germany
F Hoffmann-La Roche Limited, Basel, Switzerland
Hoffmann-La Roche Inc, Nutley, United States of America
Patheon Inc, Mississauga, Canada

Dated this 26th day of May 2010.

STEWART JESSAMINE, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health
(pursuant to delegation given by the Minister of Health on 6 July 2001).

go4119



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2010, No 61





✨ LLM interpretation of page content

🏥 Reappointment and appointments to the Physiotherapy Board

🏥 Health & Social Welfare
24 May 2010
Physiotherapy Board, Reappointment, Appointments, Health Practitioners
  • Lesley Thornley, Reappointed as health practitioner member of the Physiotherapy Board
  • Maarama Davis, Appointed as health practitioner member of the Physiotherapy Board
  • Janice Mueller, Appointed as health practitioner member of the Physiotherapy Board
  • Michéle Stanton, Appointed as lay member of the Physiotherapy Board

  • HON TONY RYALL, Minister of Health

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
26 May 2010
Medicines Act, New Medicines, Distribution Consent, Pegasys, Pegasys RBV
  • STEWART JESSAMINE, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health